SEC Form 4 · accession 0001209191-18-020924
Aclaris Therapeutics, Inc. · ACRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A. Tullman
Director
Period of report
Mar 16, 2018
Accepted (ET)
Mar 20, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 16, 2018 | J | 94,151 | $0.00 | D | 0 | I | By NST, LLC |
| Common Stock | Mar 16, 2018 | J | 9,018 | $0.00 | A | 130,807 | D | |
| Common StockF3 | holding | — | — | — | 394,014 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution by NST, LLC, of which the reporting person is a member and the sole Manager, in accordance with NST, LLC's Limited Liability Company Operating Agreement.
- F2These shares were held by NST, LLC of which the reporting person is a member and the sole Manager. The reporting person had sole voting and dispositive power over the shares held by NST, LLC.
- F3These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.